Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 5.24
+0.09 (1.75%)
Jun 16, 2026, 3:42 PM CET
Genomtec Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.03 | 0.02 | 0 | 0 | 0.04 | 0.22 | |
Revenue Growth (YoY) | 400.00% | 1800.00% | - | -97.50% | -81.73% | 995.00% |
Cost of Revenue | 7.2 | 7.2 | 4.31 | 0.79 | 3.27 | 5.38 |
Gross Profit | -7.17 | -7.18 | -4.31 | -0.79 | -3.23 | -5.16 |
Selling, General & Admin | 5.55 | 6.43 | 9.11 | 9.43 | 8.57 | 5.36 |
Other Operating Expenses | -5.06 | -4.06 | -2.36 | -1.41 | -0.31 | -3.53 |
Operating Expenses | 1.42 | 2.37 | 6.76 | 8.02 | 8.26 | 1.83 |
Operating Income | -8.59 | -9.55 | -11.06 | -8.82 | -11.49 | -7 |
Interest Expense | -0.24 | -0.26 | -0.13 | -0.12 | -0.2 | -0.03 |
Interest & Investment Income | 0.08 | 0.08 | 0.07 | 0.06 | - | - |
Currency Exchange Gain (Loss) | -0.07 | -0.07 | -0.07 | -0.13 | -0.1 | -0.09 |
Other Non Operating Income (Expenses) | -0.48 | -0.48 | -0 | -0.12 | -0.09 | - |
EBT Excluding Unusual Items | -9.3 | -10.28 | -11.2 | -9.12 | -11.88 | -7.11 |
Gain (Loss) on Sale of Assets | - | - | 0.01 | 0.08 | - | - |
Asset Writedown | 0 | 0 | 0 | 0 | - | - |
Pretax Income | -9.29 | -10.27 | -11.19 | -9.03 | -11.88 | -7.11 |
Income Tax Expense | -0.08 | -0.05 | 0.02 | -0.02 | 0.05 | 0.01 |
Net Income | -9.21 | -10.22 | -11.21 | -9.01 | -11.93 | -7.12 |
Net Income to Common | -9.21 | -10.22 | -11.21 | -9.01 | -11.93 | -7.12 |
Shares Outstanding (Basic) | 15 | 15 | 13 | 12 | 9 | 8 |
Shares Outstanding (Diluted) | 15 | 15 | 13 | 12 | 9 | 8 |
Shares Change (YoY) | 8.15% | 13.06% | 8.70% | 30.90% | 14.78% | - |
EPS (Basic) | -0.61 | -0.68 | -0.84 | -0.74 | -1.27 | -0.87 |
EPS (Diluted) | -0.61 | -0.68 | -0.84 | -0.74 | -1.27 | -0.87 |
Free Cash Flow | -9.46 | -10.95 | -6.78 | -11.48 | -7.93 | -5.71 |
Free Cash Flow Per Share | -0.63 | -0.73 | -0.51 | -0.94 | -0.85 | -0.70 |
Operating Margin | -28646.67% | -50257.90% | -1106400.00% | -881500.00% | -28730.00% | -3194.06% |
Profit Margin | -30710.00% | -53800.00% | -1120800.00% | -901300.00% | -29820.00% | -3248.86% |
Free Cash Flow Margin | -31530.00% | -57626.32% | -677500.00% | -1147900.00% | -19822.50% | -2608.68% |
EBITDA | -6.06 | -7.12 | -8.73 | -7.66 | -11.06 | -6.49 |
D&A For EBITDA | 2.53 | 2.43 | 2.33 | 1.16 | 0.44 | 0.5 |
EBIT | -8.59 | -9.55 | -11.06 | -8.82 | -11.49 | -7 |